Capital Insight Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$10.5M |
| 2 |
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
|
+$8.19M |
| 3 |
Booking.com
BKNG
|
+$4.63M |
| 4 |
Chemed
CHE
|
+$4.61M |
| 5 |
UnitedHealth
UNH
|
+$4.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$9.92M |
| 2 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$6.4M |
| 3 |
Pacira BioSciences
PCRX
|
+$1.82M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.57M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$964K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 8.46% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 6.97% |
| 5 | Industrials | 6.21% |
Similar funds
Capital Insight Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Capital Insight Partners held 172 positions worth $425M, up 10% from $386M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Insight Partners deployed $28.3M of net new capital in Q1 2023, opening 15 new positions and adding to 85 existing holdings. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 389,204 shares worth $8.26M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, up from 6.8% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $9.92M trimmed.
- Capital Insight Partners's largest Q1 2023 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 389,204 shares worth $8.26M.
- Capital Insight Partners added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $10.5M increase.
- Capital Insight Partners's biggest Q1 2023 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $9.92M.
- Capital Insight Partners fully exited Pacira BioSciences in Q1 2023, selling an estimated $1.82M.
- Capital Insight Partners's ten largest holdings make up 34% of its $425M portfolio in Q1 2023.
- Capital Insight Partners opened 15 new positions and closed 9 in Q1 2023.
- Capital Insight Partners's portfolio value rose 10% quarter-over-quarter to $425M.
Based on Capital Insight Partners's 13F filing for Q1 2023, filed 28 Apr 2023.